| scholarly article | Q13442814 |
| P2093 | author name string | Shohreh Khatami | |
| Asad Vaisi-Raygani | |||
| Mohammad Taghi Goodarzi | |||
| Masoud Taghizadeh-Jahed | |||
| Abdolreza Sabokrouh | |||
| P2860 | cites work | The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats | Q24339608 |
| Human telomerase and its regulation | Q24533247 | ||
| Apoptosis: a review of programmed cell death | Q28305845 | ||
| Telomeres and human disease: ageing, cancer and beyond | Q29615353 | ||
| Structure and function of telomeres | Q29615759 | ||
| Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines | Q30783266 | ||
| p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis | Q33862956 | ||
| Expression of the apoptosis-related genes BCL-2 and BAD in human breast carcinoma and their associated relationship with chemosensitivity | Q34075056 | ||
| An evolutionary review of human telomere biology: the thrifty telomere hypothesis and notes on potential adaptive paternal effects | Q34164417 | ||
| Telomerase and cancer | Q34188981 | ||
| Bcl-2 family proteins as targets for anticancer drug design | Q34293584 | ||
| Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. | Q34431121 | ||
| Telomeres, telomerase and senescence | Q34636650 | ||
| Recent advances in telomere biology: implications for human cancer. | Q35611262 | ||
| Telomere diseases | Q36107376 | ||
| Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma | Q36308391 | ||
| BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma | Q36621123 | ||
| Statins, Bcl-2, and apoptosis: cell death or cell protection? | Q37188822 | ||
| Correlation between chemosensitivity to anticancer drugs and Bcl-2 expression in gastric cancer | Q37277833 | ||
| Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis | Q38321543 | ||
| A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line | Q38356726 | ||
| Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics | Q38469468 | ||
| Identification of Binding Mode of a Platinum (II) Complex, PtCl(2)(DIP), and Calf Thymus DNA. | Q38833273 | ||
| Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model | Q39041944 | ||
| DNA Interaction Studies of a New Platinum(II) Complex Containing Different Aromatic Dinitrogen Ligands | Q39998591 | ||
| DNA Interaction and DNA Cleavage Studies of a New Platinum(II) Complex Containing Aliphatic and Aromatic Dinitrogen Ligands | Q40234199 | ||
| Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity | Q40395982 | ||
| Telomerase Inhibition Using Azidothymidine in the HT-29 Colon Cancer Cell Line | Q40628938 | ||
| Doses and time-dependent effects of 3'-azido-3'-deoxythymidine on T47D human breast cancer cells in vitro | Q40843825 | ||
| Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7. | Q41038735 | ||
| Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. | Q41044843 | ||
| Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues | Q41235699 | ||
| An informatics approach identifying markers of chemosensitivity in human cancer cell lines. | Q42496234 | ||
| Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status | Q42989530 | ||
| Nuclear translocation of telomerase reverse transcriptase: a critical process in chemical induced hepatocellular carcinogenesis | Q43114767 | ||
| Chronic in vitro exposure to 3'-azido-2', 3'-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells | Q43549618 | ||
| Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. | Q44302040 | ||
| AZT-DNA interaction | Q44833408 | ||
| Etoposide induces a mixed type of programmed cell death and overcomes the resistance conferred by Bcl-2 in Hep3B hepatoma cells. | Q45186762 | ||
| Anticarcinogenic effect and carcinogenic potential of the dietary phenolic acid: o-coumaric acid | Q45360523 | ||
| [Azidothymidine inhibition of telomerase activity and proliferation of TJ905 human glioblastoma cells]. | Q45941021 | ||
| Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug. | Q46132555 | ||
| Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation | Q46164975 | ||
| Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss. | Q46678519 | ||
| Lack of correlation between P53 expression, BCL-2 expression, apoptosis and ex vivo chemosensitivity in advanced human breast cancer. | Q52064760 | ||
| Alternative methods of selecting rat hepatocellular nodules resistant to 2-acetylaminofluorene. | Q54397062 | ||
| BCL-2 antisense therapy in patients with non-Hodgkin lymphoma | Q61868294 | ||
| Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines | Q71254294 | ||
| Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease | Q73047915 | ||
| The role of telomerase activity in hepatocellular carcinoma | Q73531580 | ||
| Telomerase activity in colorectal cancer and its relationship to bcl-2 expression | Q73747151 | ||
| [Radiation-induced apoptosis and p53, bcl-2 gene expression products in QGY-7703 cell line in vitro] | Q73910836 | ||
| bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice | Q74165698 | ||
| Telomerase activity and Bcl-2 expression in non-small cell lung cancer | Q74216048 | ||
| Expression profile of the putative catalytic subunit of the telomerase gene | Q74251108 | ||
| Usefulness of p53 protein, Bcl-2 protein and Ki-67 as predictors of chemosensitivity of malignant tumors | Q77325917 | ||
| Telomerase activity in hepatocellular carcinoma and adjacent liver tissues | Q77658438 | ||
| Telomerase activity and Bcl-2 expression in human breast cancer | Q77702433 | ||
| Azidothymidine treatment of hepatocellular carcinoma in rats: an in vivo study of telomerase inhibition | Q82176671 | ||
| P433 | issue | 4 | |
| P921 | main subject | zidovudine | Q198504 |
| P304 | page(s) | 200-209 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | Avicenna Journal of Medical Biotechnology | Q26842226 |
| P1476 | title | Effects of treatment with platinum azidothymidine and azidothymidine on telomerase activity and bcl-2 concentration in hepatocellular carcinoma- induced rats | |
| P478 | volume | 6 |
Search more.